Listed

Zai Lab Ltd

ZLABNasdaqCIK 1704292HealthcareFiscal year ends Dec 31

Reports and events: 163 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Zai Lab Ltd, Reports and events
FiledFormWhat it isAccession number
2026-10-2306:06 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001628280-26-066969
2026-08-0610:40 ET10-QQuarterly reportPeriod 2026-06-300001628280-26-053793
2026-08-0610:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-053791
2026-06-1720:05 ET8-K5.07 Shareholder vote results0001628280-26-043869
2026-05-2121:18 ET8-K5.02 Departure or appointment of officers or directors0001628280-26-037387
2026-05-0710:09 ET10-QQuarterly reportPeriod 2026-03-310001628280-26-031626
2026-05-0710:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-031624
2026-04-2811:16 ETDEF 14AProxy statementPeriod 2026-06-170001704292-26-000030
2026-02-2612:08 ET10-KAnnual reportPeriod 2025-12-310001704292-26-000015
2026-02-2612:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001704292-26-000014
2025-11-0612:06 ET10-QQuarterly reportPeriod 2025-09-300001704292-25-000024
2025-11-0612:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001704292-25-000023
2025-10-1620:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001704292-25-000014
2025-08-0710:23 ET10-QQuarterly reportPeriod 2025-06-300001628280-25-038548
2025-08-0710:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-25-038547
2025-06-1820:04 ET8-K5.07 Shareholder vote results0001628280-25-032099
2025-05-0810:11 ET10-QQuarterly reportPeriod 2025-03-310001628280-25-023411
2025-05-0810:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-25-023410
2025-04-2912:04 ETDEF 14AProxy statementPeriod 2025-06-180001628280-25-020478
2025-02-2711:20 ET10-KAnnual reportPeriod 2024-12-310001628280-25-008409
2025-02-2711:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-25-008406
2025-01-0321:17 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001628280-25-000261
2024-11-1522:23 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-259957
2024-11-1321:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001628280-24-047588
2024-11-1211:55 ET10-QQuarterly reportPeriod 2024-09-300001628280-24-046824
2024-11-1211:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-046809
2024-08-0620:27 ET10-QQuarterly reportPeriod 2024-06-300001628280-24-035231
2024-08-0620:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-035194
2024-07-0920:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001628280-24-031485
2024-06-1820:07 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001628280-24-028764
2024-06-1120:10 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-24-027668
2024-05-0820:14 ET10-QQuarterly reportPeriod 2024-03-310001628280-24-021689
2024-05-0820:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-021674
2024-04-2920:09 ETDEF 14AProxy statementPeriod 2024-06-180001628280-24-018995
2024-02-2721:20 ET10-KAnnual reportPeriod 2023-12-310001628280-24-007235
2024-02-2721:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-007217
2024-02-0821:37 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001628280-24-003902
2023-12-2221:29 ET10-K/AAnnual report, amendedPeriod 2022-12-310001628280-23-042643
2023-11-0721:13 ET10-QQuarterly reportPeriod 2023-09-300001628280-23-037358
2023-11-0721:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-23-037353
2023-08-0720:09 ET10-QQuarterly reportPeriod 2023-06-300001628280-23-027773
2023-08-0720:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-23-027767
2023-07-0620:14 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-23-024454
2023-06-3020:18 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-23-024042
2023-06-2020:05 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure0001628280-23-022683
2023-06-0612:08 ET8-K8.01 Other events0001628280-23-021025
2023-05-0920:10 ET10-QQuarterly reportPeriod 2023-03-310001628280-23-016816
2023-05-0920:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-23-016803
2023-04-2812:04 ETDEF 14AProxy statement0001628280-23-013769
2023-03-3110:09 ET8-K8.01 Other events0001628280-23-010007

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.